nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—Testosterone Propionate—COMT—Parkinson's disease	0.152	0.372	CrCbGaD
Drostanolone—Ursodeoxycholic acid—CYP2E1—Parkinson's disease	0.13	0.318	CrCbGaD
Drostanolone—Testosterone—MAOA—Parkinson's disease	0.0497	0.122	CrCbGaD
Drostanolone—CYP19A1—FSH signaling pathway—GRK6—Parkinson's disease	0.0487	0.0824	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—NR4A2—Parkinson's disease	0.04	0.0677	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0316	0.0535	CbGpPWpGaD
Drostanolone—Progesterone—CYP2D6—Parkinson's disease	0.0238	0.0583	CrCbGaD
Drostanolone—CYP19A1—Tryptophan metabolism—DDC—Parkinson's disease	0.0217	0.0367	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—PARK7—Parkinson's disease	0.0203	0.0343	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0201	0.0339	CbGpPWpGaD
Drostanolone—Estradiol—ABCB1—Parkinson's disease	0.02	0.0491	CrCbGaD
Drostanolone—CYP19A1—Tryptophan metabolism—MAOB—Parkinson's disease	0.0183	0.0309	CbGpPWpGaD
Drostanolone—Progesterone—ABCB1—Parkinson's disease	0.017	0.0416	CrCbGaD
Drostanolone—Testosterone—ABCB1—Parkinson's disease	0.0161	0.0394	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.0152	0.0257	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—BDNF—Parkinson's disease	0.0151	0.0255	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.0126	0.0214	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.0124	0.021	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.012	0.0202	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.011	0.0186	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0108	0.0183	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.01	0.017	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00991	0.0168	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.0099	0.0167	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.0095	0.0161	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.0089	0.015	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00814	0.0138	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—INS—Parkinson's disease	0.00797	0.0135	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00743	0.0126	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTA4—Parkinson's disease	0.00714	0.0121	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00704	0.0119	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0067	0.0113	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00639	0.0108	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—MAOB—Parkinson's disease	0.00636	0.0108	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00617	0.0104	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00615	0.0104	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00606	0.0102	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00547	0.00924	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.0053	0.00895	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2D6—Parkinson's disease	0.00473	0.00799	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.0047	0.00794	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00466	0.00788	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.0045	0.0076	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00447	0.00756	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2E1—Parkinson's disease	0.00432	0.00731	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00431	0.00729	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00426	0.00721	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00395	0.00668	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00387	0.00654	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00383	0.00647	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PRKRA—Parkinson's disease	0.00374	0.00632	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00373	0.0063	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00367	0.0062	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00364	0.00616	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00361	0.0061	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—COMT—Parkinson's disease	0.00358	0.00606	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTP1—Parkinson's disease	0.00357	0.00603	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—MAOA—Parkinson's disease	0.00356	0.00601	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—COMT—Parkinson's disease	0.00353	0.00597	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00352	0.00595	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTM1—Parkinson's disease	0.00328	0.00554	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00326	0.0055	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00323	0.00546	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NR4A2—Parkinson's disease	0.00263	0.00445	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TAF1—Parkinson's disease	0.00263	0.00445	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00247	0.00417	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00246	0.00417	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ND3—Parkinson's disease	0.00232	0.00393	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MCCC1—Parkinson's disease	0.00232	0.00393	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00221	0.00374	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—OMD—Parkinson's disease	0.00218	0.00369	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TALDO1—Parkinson's disease	0.00218	0.00369	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00216	0.00365	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00216	0.00364	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPL6—Parkinson's disease	0.0021	0.00356	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NDUFB11—Parkinson's disease	0.00207	0.0035	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GCH1—Parkinson's disease	0.00198	0.00334	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.0019	0.00322	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00183	0.0031	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00178	0.00301	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—DBH—Parkinson's disease	0.00176	0.00298	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GBA—Parkinson's disease	0.00176	0.00298	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—FBP1—Parkinson's disease	0.00176	0.00298	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00168	0.00285	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPL14—Parkinson's disease	0.00159	0.0027	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPL23A—Parkinson's disease	0.00159	0.0027	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00157	0.00265	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPS8—Parkinson's disease	0.00149	0.00251	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00133	0.00225	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—DDC—Parkinson's disease	0.00129	0.00219	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00126	0.00214	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTA4—Parkinson's disease	0.00122	0.00206	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00121	0.00204	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HSPA8—Parkinson's disease	0.00119	0.00201	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CTGF—Parkinson's disease	0.00119	0.00201	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	0.0011	0.00186	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MAOB—Parkinson's disease	0.00109	0.00184	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HSPA1A—Parkinson's disease	0.00108	0.00183	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00104	0.00175	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	0.000809	0.00137	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CTGF—Parkinson's disease	0.000794	0.00134	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	0.00074	0.00125	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NQO1—Parkinson's disease	0.000731	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TH—Parkinson's disease	0.000721	0.00122	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYCS—Parkinson's disease	0.000692	0.00117	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—COMT—Parkinson's disease	0.000613	0.00104	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTP1—Parkinson's disease	0.00061	0.00103	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MAOA—Parkinson's disease	0.000608	0.00103	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HMOX1—Parkinson's disease	0.000601	0.00102	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCB1—Parkinson's disease	0.000577	0.000976	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTM1—Parkinson's disease	0.00056	0.000947	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GPX1—Parkinson's disease	0.000537	0.000907	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTHFR—Parkinson's disease	0.000495	0.000837	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOE—Parkinson's disease	0.000461	0.00078	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—INS—Parkinson's disease	0.000394	0.000666	CbGpPWpGaD
